Quick Answer
AGIOS PHARMACEUTICALS, INC. reported Stockholders Equity of $1.19 billion for fiscal year 2025.
AGIOS PHARMACEUTICALS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $1.19B | -22.6% |
| 2024 | $1.54B | +90.0% |
| 2023 | $811.02M | -26.3% |
| 2022 | $1.10B | -14.8% |
| 2021 | $1.29B | +223.4% |
| 2020 | $399.50M | -37.6% |
| 2019 | $640.53M | -6.8% |
| 2018 | $687.54M | +83.1% |
| 2017 | $375.50M | +4.7% |
| 2016 | $358.59M | +3.9% |
| 2015 | $345.12M | -18.7% |
| 2014 | $424.37M | +222.8% |
| 2013 | $131.48M | +282.6% |
| 2012 | -$72.02M | -36.5% |
| 2011 | -$52.78M | -78.4% |
| 2010 | -$29.59M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.28B | -21.0% | -6.2% |
| June 30, 2025 | $1.37B | +107.3% | -6.6% |
| March 31, 2025 | $1.47B | +97.1% | -4.8% |
| December 31, 2024 | $1.54B | +90.0% | -5.3% |
| September 30, 2024 | $1.63B | +83.4% | +146.3% |
| June 30, 2024 | $660.51M | -31.5% | -11.2% |
| March 31, 2024 | $743.92M | -28.2% | -8.3% |
| December 31, 2023 | $811.02M | -26.3% | -8.5% |
- AGIOS PHARMACEUTICALS, INC. showed a decrease of -22.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2010–2025 period, AGIOS PHARMACEUTICALS, INC.’s stockholders equity has grown by 4132.0% (from -$29.59 million to $1.19 billion).
- The most recent figure is from AGIOS PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: